Reviewing GN Store Nord A/S (GGNDF) and Abbott Laboratories (ABT)

GN Store Nord A/S (OTCMKTS:GGNDF) and Abbott Laboratories (NYSE:ABT) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk and earnings.

Earnings and Valuation

This table compares GN Store Nord A/S and Abbott Laboratories’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
GN Store Nord A/S N/A N/A N/A N/A N/A
Abbott Laboratories $30.58 billion 4.59 $2.37 billion $2.88 27.76

Abbott Laboratories has higher revenue and earnings than GN Store Nord A/S.

Dividends

Abbott Laboratories pays an annual dividend of $1.28 per share and has a dividend yield of 1.6%. GN Store Nord A/S does not pay a dividend. Abbott Laboratories pays out 44.4% of its earnings in the form of a dividend. Abbott Laboratories has raised its dividend for 46 consecutive years.

Analyst Recommendations

This is a summary of recent ratings and price targets for GN Store Nord A/S and Abbott Laboratories, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GN Store Nord A/S 0 0 0 0 N/A
Abbott Laboratories 1 3 14 0 2.72

Abbott Laboratories has a consensus price target of $79.69, indicating a potential downside of 0.33%. Given Abbott Laboratories’ higher probable upside, analysts clearly believe Abbott Laboratories is more favorable than GN Store Nord A/S.

Profitability

This table compares GN Store Nord A/S and Abbott Laboratories’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
GN Store Nord A/S N/A N/A N/A
Abbott Laboratories 7.74% 16.55% 7.38%

Institutional and Insider Ownership

74.1% of Abbott Laboratories shares are held by institutional investors. 0.7% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Abbott Laboratories beats GN Store Nord A/S on 10 of the 11 factors compared between the two stocks.

About GN Store Nord A/S

GN Store Nord A/S develops, manufactures, and markets medical, professional, and consumer audio solutions. The company operates through GN Hearing and GN Audio segments. The GN Hearing segment produces and sells hearing instruments and products. The GN Audio segment supplies headsets and speakerphone solutions primarily for professional use; and consumer headsets and earbuds for calls, music, and media consumption. It offers its products under the ReSound, Beltone, Interton, Jabra, and VXi and Blueparrott brand names. The company markets and sells its products in approximately 100 countries. The company has a strategic collaboration with Cochlear Limited to focus on improving hearing outcomes in patients with cochlear implants. GN Store Nord A/S was founded in 1869 and is based in Ballerup, Denmark.

About Abbott Laboratories

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptom; gynecological disorder; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraine; and anti-infective clarithromycin, as well as provides influenza vaccines and products that regulate physiological rhythm of the colon. Its Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; rapid diagnostics systems for infectious diseases; molecular point-of-care care testing for HIV, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company also provides glucose and blood glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.

Receive News & Ratings for GN Store Nord A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GN Store Nord A/S and related companies with MarketBeat.com's FREE daily email newsletter.